Results 171 to 180 of about 19,211 (198)
Some of the next articles are maybe not open access.
Generation and Evaluation of a CYP2C9 Heteroactivation Pharmacophore
The Journal of Pharmacology and Experimental Therapeutics, 2003Positive cooperativity (auto- and heteroactivation) of drug oxidation, a potential cause of drug interactions, is well established in vitro for cytochrome P450 (P450) 3A4 but to a much lesser extent for other drug-metabolizing P450 isoforms. Using a high throughput fluorescent-based CYP2C9 effector assay, we identified >30 heteroactivators from a set ...
Egnell, Ann Charlotte +4 more
openaire +2 more sources
2014
???????????????? ???????????? ???????????????????????????? ???????????????????? ?????????????????????? ?????????????????? 430?? > ?? ?? 1075?? > ?? ???????? ?????????????????? ??450 CYP2C9 ?? ?????????????? ?????????????????????? ?????????????????? ?? ?? ?????????????? ???????????????? ?????? ?????????????????? ??????????????????. ????????????????, ????
openaire +1 more source
???????????????? ???????????? ???????????????????????????? ???????????????????? ?????????????????????? ?????????????????? 430?? > ?? ?? 1075?? > ?? ???????? ?????????????????? ??450 CYP2C9 ?? ?????????????? ?????????????????????? ?????????????????? ?? ?? ?????????????? ???????????????? ?????? ?????????????????? ??????????????????. ????????????????, ????
openaire +1 more source
Functional impact of CYP2C9*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans*1
Clinical Pharmacology & Therapeutics, 2004openaire +1 more source
Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes
Archives of Pharmacal Research, 2022Seok-Yong Lee +2 more
exaly
Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis
European Journal of Clinical Pharmacology, 2008Jonatan Lindh +2 more
exaly
Functional characterization of 32 CYP2C9 allelic variants
Pharmacogenomics Journal, 2013Masahiro Hiratsuka, Noriyasu Hirasawa
exaly

